Aeterna Zentaris Inc. - AEZS Net earnings per one share for the last twelve months

Aeterna Zentaris Inc (AEZS) - corporate logo

Aeterna Zentaris (AEZS) automates molecular bioscreening using AI and robotics, eliminating manual labor. The growth rate history of net income per share YoY ttm illustrates the commercialization of endocrinology tests and drugs. The value of -77.30 reflects the baseline level of the metric. Patent protection for orphan systems creates a powerful barrier for competitors, ensuring market exclusivity.

AEZS: Aeterna Zentaris Inc. Net earnings per share for the last 12 months 02/11/2024 - 02/20/2024

Aeterna Zentaris Inc. - analytical breakdowns and key metrics (AEZS)

- issuer market value details:
Fundamental company valuation:AEZS - Zentaris
Brand item of zentaris.com

The synergy of the updated development portfolio of Aeterna Zentaris (AEZS) requires confirmation through earnings per share efficiency. This metric measures the percentage change in EPS over a rolling year, revealing the actual business resilience between quarterly reports. It determines the extent to which the current financial trajectory is supported by fundamental revenue growth. By analyzing the EPS dynamics over the last 12 months YoY, an investor can see the company's margin of safety during the management's operational adaptation period.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Applied Therapeutics APLT|RNTX - Earnings per share for the last twelve months|Net earnings per share for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Net earnings per share for the last 12 months|Chemomab Therapeutics Ltd - Earnings per share for the trailing year|Net earnings per share for the last 12 months SRXH|Earnings per share for the last twelve months PLRZ|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)